Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transmitted raltegravir resistance in an HIV-1 CRF_AG-infected patient.

Antiviral therapy - 1 Jan 2011

Boyd Sarita D, Maldarelli Frank, Sereti Irini, Ouedraogo G Laissa, Rehm Catherine A, Boltz Valerie, Shoemaker Diana, Pau Alice K

Abstract excerpt

Here, we describe an HIV-infected patient with pretreatment resistance to raltegravir, nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors and protease inhibitors, and the ultimate ability to achieve viral suppression. Pretreatment integrase resistance testing is not routinely performed because transmitted integrase mutations conferring resistance to raltegravir are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to HIV Integrase Inhibitors

Share to Pyrrolidinones

Share to Raltegravir Potassium

Share to Viral Load

Source

Open in PubMed Open full text

Identifiers

PMID: 21447876
DOI: 10.3851/IMP1749
PMCID: PMC3150494

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transmitted raltegravir resistance in an HIV-1 CRF_AG-infected patient.PMID 21447876Read ↗

High-level multi-class transmitted antiretroviral resistance in a man with newly acquired HIV.Semantic proximity Read ↗

Understanding transmitted HIV resistance through the experience in the USA.Semantic proximity Read ↗

HIV-2 integrase polymorphisms and longitudinal genotypic analysis of HIV-2 infected patients failing a raltegravir-containing regimen.Semantic proximity Read ↗

Drug resistance profiles for the HIV integrase gene in patients failing raltegravir salvage therapy.Semantic proximity Read ↗

Integrase strand transfer inhibitor resistance mediated by R263K plus E157Q in a patient with HIV infection treated with bictegravir/tenofovir alafenamide/emtricitabine: case report and review of the literatureSemantic proximity Read ↗

Transmitted resistance to HIV integrase strand-transfer inhibitors: right on schedule.Semantic proximity Read ↗

An HIV-1 integrase genotype assay for the detection of drug resistance mutations.Semantic proximity Read ↗

The HIV-1 integrase genotype strongly predicts raltegravir susceptibility but not viral fitness of primary virus isolates.Semantic proximity Read ↗

Preliminary report of transmitted drug resistance to integrase strand chain transfer inhibitors in treatment-naïve HIV infected patients.Semantic proximity Read ↗

Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection.Semantic proximity Read ↗

Canary in the Coal Mine? Transmitted Mutations Conferring Resistance to All Integrase Strand Transfer Inhibitors in a Treatment-Naive PatientSemantic proximity Read ↗

Genotypic/phenotypic patterns of HIV-1 integrase resistance to raltegravir.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.